Randomized Trial on Adjuvant Chemotherapy in Colon Carcinoma Dukes B

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04089631` - Circulating Tumour DNA Based Decision for Adjuvant Treatment in Colon Cancer Stage II Evaluation	Phase 3
Active, not recruiting	`NCT05421702` - Comparison Between Results of 2 Laparoscopic Surgical Procedures in Operable Colon Cancer Cases in Upper Egypt	N/A
Recruiting	`NCT06108310` - ArTificial inTelligence-based RAdiogenomics in Colon Tumors
Recruiting	`NCT05194878` - Neoadjuvant FOLFOXIRI Versus Immediate Surgery for Stage II and III Colon Cancers	Phase 3

See also

Status

Clinical Trial

Phase

Recruiting

NCT04089631 - Circulating Tumour DNA Based Decision for Adjuvant Treatment in Colon Cancer Stage II Evaluation

Phase 3

Active, not recruiting

NCT05421702 - Comparison Between Results of 2 Laparoscopic Surgical Procedures in Operable Colon Cancer Cases in Upper Egypt

N/A

Recruiting

NCT06108310 - ArTificial inTelligence-based RAdiogenomics in Colon Tumors

Recruiting

NCT05194878 - Neoadjuvant FOLFOXIRI Versus Immediate Surgery for Stage II and III Colon Cancers

Phase 3

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT00309543
Study type	Interventional
Source	Austrian Breast & Colorectal Cancer Study Group
Contact
Status	Completed
Phase	Phase 3
Start date	November 1993

Randomized Trial on Adjuvant Chemotherapy in Colon Carcinoma Dukes B

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms